HI
ANIP icon

Harbour Investments’s ANI Pharmaceuticals ANIP Stock Holding History

Harbour Investments’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.2K Hold
123
– – ﹤0.01% 3348
2026
Q1 		$9.46K Buy
123
+91
+284% +$7.1K ﹤0.01% 3286
2025
Q4 		$2.53K Buy
+32
New +$2.77K ﹤0.01% 3248
2024
Q4 		– Sell
-1
Closed -$60 – 3489
2024
Q3 		$60 Sell
1
-1
-50% -$61 ﹤0.01% 3341
2024
Q2 		$127 Hold
2
– – ﹤0.01% 3194
2024
Q1 		$138 Hold
2
– – ﹤0.01% 3137
2023
Q4 		$110 Hold
2
– – ﹤0.01% 3042
2023
Q3 		$116 Hold
2
– – ﹤0.01% 2915
2023
Q2 		$108 Hold
2
– – ﹤0.01% 2944
2023
Q1 		$79 Hold
2
– – ﹤0.01% 2936
2022
Q4 		$80 Hold
2
– – ﹤0.01% 2938
2022
Q3 		$0 Hold
2
– – ﹤0.01% 2714
2022
Q2 		$0 Buy
+2
New +$58 ﹤0.01% 2714
2021
Q4 		$0 Sell
2
-495
-100% -$21.3K ﹤0.01% 2651
2021
Q3 		$16K Buy
497
+1
+0.2% +$31 ﹤0.01% 2401
2021
Q2 		$17K Sell
496
-175
-26% -$5.95K ﹤0.01% 2416
2021
Q1 		$24K Buy
+671
New +$21K ﹤0.01% 2103

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harbour Investments's ANIP Position: Q2 2026 in Review

Harbour Investments held its ANI Pharmaceuticals (ANIP) position steady in Q2 2026 at 123 shares worth $10.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3348.

Harbour Investments first reported a position in ANIP in Q1 2021 and has held it in 17 quarters since. The position peaked at $24K in Q1 2021. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Harbour Investments held 123 shares of ANI Pharmaceuticals worth $10.2K as of Q2 2026.
  • Harbour Investments left its ANI Pharmaceuticals share count unchanged in Q2 2026.
  • ANI Pharmaceuticals made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #3348 holding.
  • Harbour Investments first reported a position in ANI Pharmaceuticals in Q1 2021 and has held it in 17 quarters since.
  • Harbour Investments's ANI Pharmaceuticals position peaked at $24K in Q1 2021.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.